Glenn Laffel

3.4k total citations · 2 hit papers
23 papers, 2.3k citations indexed

About

Glenn Laffel is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Health Information Management. According to data from OpenAlex, Glenn Laffel has authored 23 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 4 papers in Cardiology and Cardiovascular Medicine and 4 papers in Health Information Management. Recurrent topics in Glenn Laffel's work include Healthcare Quality and Management (4 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Transplantation: Methods and Outcomes (3 papers). Glenn Laffel is often cited by papers focused on Healthcare Quality and Management (4 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Transplantation: Methods and Outcomes (3 papers). Glenn Laffel collaborates with scholars based in United States and Vietnam. Glenn Laffel's co-authors include Robert K. Hallisey, Eugene Braunwald, Jeffrey S. Cooper, David W. Bates, Harold J. DeMonaco, David Blumenthal, Gilbert H. Mudge, Meryl S. LeBoff, Arnold Barnett and Michael P. Kaye and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of the American College of Cardiology.

In The Last Decade

Glenn Laffel

23 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.

1995 907 citations Glenn Laffel, Robert K. Hallisey et al. PubMed profile →
Systems analysis of adverse drug events. ADE Prevention Study Group.

1995 495 citations David W. Bates, Jeffrey S. Cooper et al. PubMed profile →

Peers

Glenn Laffel

EMS

GG

HIM

SURGE

CCM

Jonathan R. Nebeker United States

Andrew S. Karson United States

Frank Federico United States

D. W. Bates United States

Gordon D. Schiff United States

Sarah P. Slight United Kingdom

Robert K. Hallisey United States

Nicholas Barber United Kingdom

Julie Fiskio United States

Catherine Yoon United States

Jonathan R. Nebeker United States

Glenn Laffel

656 ×0.7

EMS

882 ×1.1

GG

594 ×1.1

HIM

560 ×1.7

SURGE

395 ×1.2

CCM

Citations per year, relative to Glenn Laffel Glenn Laffel (= 1×) peers Jonathan R. Nebeker

Countries citing papers authored by Glenn Laffel

Since Specialization

Citations

This map shows the geographic impact of Glenn Laffel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenn Laffel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenn Laffel more than expected).

Fields of papers citing papers by Glenn Laffel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenn Laffel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenn Laffel. The network helps show where Glenn Laffel may publish in the future.

Co-authorship network of co-authors of Glenn Laffel

This figure shows the co-authorship network connecting the top 25 collaborators of Glenn Laffel. A scholar is included among the top collaborators of Glenn Laffel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenn Laffel. Glenn Laffel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Laffel, Glenn, et al.. (1995). Developing a Corporate-Level Performance Assessment System. Quality Management in Health Care. 3(4). 62–70. 1 indexed citations

2.

Laffel, Glenn, et al.. (1995). Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.. PubMed. 274(1). 29–34. 907 indexed citations breakdown →

3.

Laffel, Glenn, et al.. (1995). Using PERT/CPM To Design and Improve Clinical Processes. Quality Management in Health Care. 3(2). 1–13. 27 indexed citations

4.

Bates, David W., et al.. (1995). Systems analysis of adverse drug events. ADE Prevention Study Group.. PubMed. 274(1). 35–43. 495 indexed citations breakdown →

5.

Laffel, Glenn. (1995). Community Health Information Networks. Quality Management in Health Care. 3(2). 85–86. 2 indexed citations

6.

Seltzer, Steven E., et al.. (1994). Expediting the turnaround of radiology reports: use of total quality management to facilitate radiologists' report signing.. American Journal of Roentgenology. 162(4). 775–781. 47 indexed citations

7.

Laffel, Glenn, et al.. (1994). Assessing organizational performance. Quality Management in Health Care. 2(4). 44–45. 15 indexed citations

8.

Laffel, Glenn, et al.. (1994). Assessing organizational performance. Quality Management in Health Care. 2(4). 44–45. 4 indexed citations

9.

Laffel, Glenn. (1993). Quality Health Care. JAMA. 270(2). 254–254. 11 indexed citations

10.

Laffel, Glenn, et al.. (1993). The customer-Driven Company. Quality Management in Health Care. 1(4). 83–83. 4 indexed citations

11.

Laffel, Glenn, et al.. (1993). The customer-Driven Company. Quality Management in Health Care. 1(4). 83–83. 5 indexed citations

12.

Laffel, Glenn, Arnold Barnett, Stan N. Finkelstein, & Michael P. Kaye. (1992). The Relation between Experience and Outcome in Heart Transplantation. New England Journal of Medicine. 327(17). 1220–1225. 74 indexed citations

13.

Mudge, Gilbert H., et al.. (1992). Cyclosporine A and prednisone-associated osteoporosis in heart transplant recipients.. PubMed. 11(5). 950–8. 91 indexed citations

14.

Laffel, Glenn. (1991). Implementing quality management in health care: The challenges ahead. Quality Engineering. 36(7). 427–428. 3 indexed citations

15.

Kleefield, Sharon, William Churchill, & Glenn Laffel. (1991). Quality Improvement in a Hospital Pharmacy Department. QRB - Quality Review Bulletin. 17(5). 138–143. 9 indexed citations

16.

Kuo, Paul C., James M. Kirshenbaum, John B. Gordon, et al.. (1989). Lovastatin therapy for hypercholesterolemia in cardiac transplant recipients. The American Journal of Cardiology. 64(10). 631–635. 41 indexed citations

17.

Laffel, Glenn. (1989). The Case for Using Industrial Quality Management Science in Health Care Organizations. JAMA. 262(20). 2869–2869. 240 indexed citations

18.

Laffel, Glenn & David Blumenthal. (1989). The case for using industrial quality management science in health care organizations.. PubMed. 262(20). 2869–73. 93 indexed citations

19.

Laffel, Glenn, Harvey V. Fineberg, & Eugene Braunwald. (1987). A cost-effectiveness model for coronary thrombolysis/reperfusion therapy. Journal of the American College of Cardiology. 10(5). 79B–90B. 45 indexed citations

20.

Laffel, Glenn & Eugene Braunwald. (1984). Thrombolytic Therapy. New England Journal of Medicine. 311(11). 710–717. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact